Global Health Limited

BSE:543654 Stock Report

Market Cap: ₹296.0b

Global Health Valuation

Is 543654 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 543654 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 543654 (₹1102.6) is trading above our estimate of fair value (₹561.37)

Significantly Below Fair Value: 543654 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 543654?

Key metric: As 543654 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 543654. This is calculated by dividing 543654's market cap by their current earnings.
What is 543654's PE Ratio?
PE Ratio60.6x
Earnings₹4.88b
Market Cap₹295.99b

Price to Earnings Ratio vs Peers

How does 543654's PE Ratio compare to its peers?

The above table shows the PE ratio for 543654 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average69.7x
NH Narayana Hrudayalaya
33x13.6%₹256.7b
KIMS Krishna Institute of Medical Sciences
72.3x24.3%₹239.7b
ASTERDM Aster DM Healthcare
96.9x37.5%₹218.9b
FORTIS Fortis Healthcare
76.5x26.8%₹501.7b
543654 Global Health
60.6x20.2%₹296.0b

Price-To-Earnings vs Peers: 543654 is good value based on its Price-To-Earnings Ratio (60.6x) compared to the peer average (69.7x).

Price to Earnings Ratio vs Industry

How does 543654's PE Ratio compare vs other companies in the IN Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.96m
No more companies available in this PE range
543654 60.6xIndustry Avg. 44.2xNo. of Companies6PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 543654 is expensive based on its Price-To-Earnings Ratio (60.6x) compared to the Indian Healthcare industry average (43.1x).

Price to Earnings Ratio vs Fair Ratio

What is 543654's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

543654 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio60.6x
Fair PE Ratio62.9x

Price-To-Earnings vs Fair Ratio: 543654 is good value based on its Price-To-Earnings Ratio (60.6x) compared to the estimated Fair Price-To-Earnings Ratio (62.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 543654 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,102.60
₹1,184.25
+7.4%
13.3%₹1,440.00₹855.00n/a12
Nov ’25₹1,115.50
₹1,193.36
+7.0%
12.5%₹1,400.00₹895.00n/a11
Oct ’25₹1,001.05
₹1,207.18
+20.6%
12.5%₹1,400.00₹930.00n/a11
Sep ’25₹1,133.85
₹1,233.90
+8.8%
10.4%₹1,390.00₹980.00n/a10
Aug ’25₹1,223.90
₹1,393.00
+13.8%
6.3%₹1,490.00₹1,245.00n/a9
Jul ’25₹1,271.20
₹1,376.10
+8.3%
10.3%₹1,620.00₹1,089.00n/a10
Jun ’25₹1,192.90
₹1,376.10
+15.4%
10.3%₹1,620.00₹1,089.00n/a10
May ’25₹1,444.90
₹1,352.70
-6.4%
9.8%₹1,530.00₹1,089.00n/a10
Apr ’25₹1,329.60
₹1,336.33
+0.5%
9.6%₹1,470.00₹1,089.00n/a9
Mar ’25₹1,298.60
₹1,336.33
+2.9%
9.6%₹1,470.00₹1,089.00n/a9
Feb ’25₹1,196.60
₹992.00
-17.1%
9.4%₹1,120.00₹875.00n/a9
Jan ’25₹951.45
₹958.63
+0.8%
6.9%₹1,050.00₹875.00n/a8
Dec ’24₹971.10
₹958.63
-1.3%
6.9%₹1,050.00₹875.00n/a8
Nov ’24₹800.90
₹790.00
-1.4%
5.7%₹859.00₹735.00₹1,115.508
Oct ’24₹715.50
₹780.14
+9.0%
5.0%₹840.00₹735.00₹1,001.057
Sep ’24₹707.25
₹754.33
+6.7%
3.1%₹780.00₹720.00₹1,133.856
Aug ’24₹678.85
₹687.80
+1.3%
7.9%₹780.00₹620.00₹1,223.905
Jul ’24₹659.65
₹667.50
+1.2%
4.8%₹710.00₹620.00₹1,271.204
Jun ’24₹586.90
₹653.33
+11.3%
3.7%₹675.00₹620.00₹1,192.903
May ’24₹514.75
₹585.00
+13.6%
5.7%₹630.00₹550.00₹1,444.903
Apr ’24₹526.15
₹602.50
+14.5%
4.6%₹630.00₹575.00₹1,329.602
Mar ’24₹509.85
₹602.50
+18.2%
4.6%₹630.00₹575.00₹1,298.602

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Yatharth Hospital & Trauma Care Services

₹51.9b

Owns and operates super-specialty hospitals in Delhi and Madhya Pradesh.

543950

₹604.50

7D

0.02%

1Y

39.9%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.00

7D

-3.9%

1Y

n/a

N G Industries

₹565.2m

Provides various healthcare services in India.

530897

₹168.70

7D

-0.3%

1Y

0.8%